ConductScience.org, home

Library / Trial comparisons

Cases vs Controls: Prevalence of Actinic Keratoses in Adult People Diagnosed With Vitiligo

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.01750.01450.021wilsonClinicalTrials.gov
Risk in group 20.01430.01290.0158wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.00318-0.0001310.00697newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.220.9911.51logClinicalTrials.gov
Odds ratio, group 1 over group 21.230.991.52logClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on Cases than on Controls314from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Cases
Patients with a confirmed diagnosis of Vitiligo within the study period will be included as cases for analysis.~Exposure of skin cancer of interest: Melanoma and nonmelanoma skin cancers: squamous cell carcinoma, basal cell carcinoma and actinic keratoses.
1116,360OG000ClinicalTrials.gov
Group 2Controls
The controls will be defined by matching cases with people who have never been diagnosed with vitiligo either prior to or during the study period, by age and sex, at General Practice level.~Exposure of skin cancer of interest: Melanoma and nonmelanoma skin cancers: squamous cell carcinoma, basal cell carcinoma and actinic keratoses.
36325,439OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitlePrevalence of Actinic Keratoses in Adult People Diagnosed With VitiligoClinicalTrials.gov
DescriptionPrevalence of actinic keratoses in adult people diagnosed with vitiligo at or before recruitmentClinicalTrials.gov
Time frameAt index date.ClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleIncidence of Melanoma and Non-melanoma Skin Cancer in People With VitiligoClinicalTrials.gov
NCT numberNCT04969419ClinicalTrials.gov
PhasesClinicalTrials.gov
ConditionsVitiligo, Melanoma (Skin), Nonmelanoma Skin Cancer, Squamous Cell Carcinoma, Basal Cell Carcinoma, Actinic KeratosesClinicalTrials.gov
InterventionsExposure of skin cancer of interestClinicalTrials.gov
Lead sponsorMomentum DataClinicalTrials.gov
Results first posted2025-01-14ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT04969419?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.